Search - tctmd.com

Displaying 221 - 240 of 307

Sort: Relevancy | Date

News Industry News

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

April 07, 2015

News Industry News

St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter

January 26, 2015

News Industry News

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

January 07, 2015

News Industry News

Abbott Expands Its Medical Device Business with Acquisition In Catherter-Based Electrophysiology Market

October 29, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Industry News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

July 22, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Industry News

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

May 07, 2014

News Industry News

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

May 05, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Industry News

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

March 21, 2014

Advertisement

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

Abbott Expands Its Medical Device Business with Acquisition In Catherter-Based Electrophysiology Market

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

Renal Denervation Shows Promise in Patients Refractory to Stenting

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content